Guidelines for perioperative haemodynamic optimization

Annales Francaises d'Anesthesie et de Reanimation

Volumn 32, Issue 10, 2013, Pages

  Vallet, B ^a   Blanloeil, Y ^b   Cholley, B ^c   Orliaguet, G ^d   Pierre, S ^e   Tavernier, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CHU de Nantes   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Guidelines; Perioperative haemodynamic optimization

Indexed keywords

ANTIEMETIC AGENT; CARBOHYDRATE; GLUCOSE; MORPHINE; SODIUM CHLORIDE;

AGE DISTRIBUTION; ANESTHETIC RECOVERY; ARTICLE; COMORBIDITY; CRYSTALLOID; ELECTROLYTE INTAKE; FLUID RESUSCITATION; FOOD INTAKE; HEART STROKE VOLUME; HEMODYNAMIC MONITORING; HEMODYNAMIC STRESS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MORBIDITY; NAUSEA; PEDIATRICS; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PROCESS OPTIMIZATION; RISK REDUCTION; SURGICAL PATIENT; VOMITING;

GUIDELINES; PERIOPERATIVE HAEMODYNAMIC OPTIMIZATION; RECOMMANDATIONS; REMPLISSAGE VASCULAIRE PÉRIOPÉRATOIRE;

ADULT; ANALGESIA, EPIDURAL; ANALGESIA, OBSTETRICAL; ANTIEMETICS; CESAREAN SECTION; CHILD; FEMALE; FLUID THERAPY; HEMODYNAMICS; HUMANS; ISOTONIC SOLUTIONS; MONITORING, INTRAOPERATIVE; PERIOPERATIVE CARE; PLASMA SUBSTITUTES; POSTOPERATIVE NAUSEA AND VOMITING; PREGNANCY; STROKE VOLUME;

EID: 84886502216     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2013.09.010     Document Type: Article

References (27)

1. Guyton A.C. Determination of cardiac output by equating venous return curves with cardiac response curves. Rev Physiol 1955, 35:123-129.
2. Sinclair S., James S., Singer M. Intraoperative intravascular volume optimization and length of hospital stay after repair of proximal femoral fracture: randomized controlled trial. BMJ 1997, 315:909-912.
3. Venn R., Steele A., Richardson P., Poloniecki J., Grounds M., Newman P. Randomized controlled trial to investigate impact of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth 2002, 88:65-71.
4. Brandstrup B., Tønnesen H., Beier-Holgersen R., Hjortsø E., Ørding H., Lindorff-Larsen K., et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid Regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003, 238:641-648.
5. Nisanevich V., Felsenstein I., Almogy G., Weissman C., Einav S., Matot I. Effect of intraoperative fluid management on outcome Effective intraabdominal surgery. Anesthesiology 2005, 103:25-32.
6. Teboul J.L. Groupe d'experts de la SRLF. Recommandations d'experts de la SRLF. Indicateurs du remplissage vasculaire au cours de l'insuffisance circulatoire. Ann Fr Anesth Reanim 2005, 24:568-576. experts group SRLF.
7. Tibby S.M., Murdoch I.A. Monitoring cardiac function in intensive care. Arch Dis Child 2003, 88:46-52.
8. Phan T.D., Ismail H., Heriot A.G., Ho K.M. Improving perioperative outcomes: fluid optimization with the esophageal Doppler monitor, a metaanalysis and review. J Am Coll Surg 2008, 207:935-941.
9. Cannesson M., Le Manach Y., Hofer C.K., Goarin J.P., Lehot J.J., Vallet B., et al. Assessing the diagnostic accuracy of pulse pressure variations for the prediction of fluid responsiveness: a "gray zone" approach. Anesthesiology 2011, 115:231-241.
10. CannessonM, Desebbe O., Rosamel P., Delannoy B., Robin J., Bastien O., et al. Pleth variability index to monitor the respiratory variations in the pulse oximeter plethysmographic waveform amplitude and predict fluid responsiveness in the operating theater. Br J Anaesth 2008, 101:200-206.
11. Zimmermann M., Feibicke T., Keyl C., Prasser C., Moritz S., Graf B.M., et al. Accuracy of stroke volume variation compared with pleth variability index to predict fluid responsiveness in mechanically ventilated patients Undergoing major surgery. Eur J Anaesthesiol 2010, 27:555-561.
12. Hamilton M.A., Cecconi M., Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic response to Improve postoperative outcomes in moderate and high-risk surgical patients. Anesth Analg 2011, 112:1392-1402.
13. Atkins D., Best D., Briss P.A., Eccles M., Falck-Ytter Y., Flottorp S., et al. Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490.
14. Copeland G.P., Jones D., Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 1991, 78:355-360.
15. Rioux J.P., Lessard M., De Bortoli B., Roy P., Albert M., Verdant C., et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 2009, 37:1293-1298.
16. Winkelmayer W.C., Glynn R.J., Levin R., Avorn J. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 2003, 64:1046-1049.
17. Mahmood A., Gosling P., Vohra R.K. Randomized Clinical Trial Comparing the effects on renal function of hydroxyethyl starch or gelatine falling on aortic aneurysm surgery. Br J Surg 2007, 94:427-433.
18. Mukhtar A., Aboulfetouh F., Obayah G., Salah M., Emam M., Khater Y., et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg 2009, 109:924-930.
19. Godet G., Lehot J.J., Jan G., Steib A., De Castro V., Coriat P. Safety of HES 130/0.4 (Voluven (R)) in patients with preoperative renal dysfunction Undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicenter trial. Eur J Anaesthesiol 2008, 25:986-994.
20. Fenger-Eriksen C., Hartig Rasmussen C., Kappel Jensen T., Anker-Møller E., Heslop J., Frøkiaer J., et al. Renal effects of hypotensive anesthesia in combination with acute normovolaemic haemodilution with hydroxyethyl starch 130/0.4 or isotonic saline. Acta Anaesthesiol Scand 2005, 49:969-974.
21. Wu Y., Wu A.S., Wang J., Tian M., Jia X.Y., Rui Y., et al. Effects of the novel 6% hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation. Chin Med J (Engl) 2010, 123:3079-3083.
22. Dart A.B., Mutter T.C., Ruth C.A., Taback S.P. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010, 20:CD007594.
23. Hartog C.S., Kohl M., Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011, 112:635-645.
24. Groeneveld A.B., Navickis R.J., Wilkes M.M. Update on the comparative safety of colloids: a systematic review of clinical studies. Ann Surg 2011, 253:470-483.
25. Kozek-Langenecker S.A., Jungheinrich C., Sauermann W., Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008, 107:382-390.
26. Sümpelmann R., Becke K., Crean P., Jöhr M., Lönnqvist P.A., Strauss J.M., et al. European consensus statement for intraoperative fluid therapy in children. Eur J Anaesthesiol 2011, 28:637-639.
27. Furman E.B., Roman D.G., Lemmer L.A., Hairabet J., Jasinska M., Laver M.B. Specific therapy in water, electrolyte and blood-volume replacement falling on pediatric surgery. Anesthesiology 1975, 42:187-193.